Case Study: Scaling Corganics’ Clinically Trusted Mission with Authentic, Founder-Led Storytelling

Client Overview

Company: Corganics

Industry: Healthcare, Pain Management

Audience: Physicians, healthcare administrators, surgical teams, and rehab specialists

The Challenge

Corganics produces clinically trusted CBD products aimed at providing a safe, non-opioid alternative for pain management after surgery. While the products are backed by rigorous science—Advanced Lipid Technology, IRB approval, third-party testing—the company faced significant communication barriers:

• Limited reach beyond one-on-one physician conversations

• Overly polished marketing that lacked authenticity

• Founders too focused on innovation to maintain high-volume media production

In a high-trust, time-constrained healthcare environment, traditional marketing was failing to connect.

The Strategic Opportunity

The healthcare market is at a tipping point in the shift toward opioid alternatives:

• 130+ opioid-related deaths occur daily in the U.S., with ~40% tied to prescriptions

• Hospitals adopting multimodal analgesia are reducing opioid use by up to 50%

• The global opioid alternatives market was valued at $15.8B in 2024, projected to double by 2033

Corganics needed a way to scale authentic, credible messaging to capitalize on this momentum.

Campaign Execution

UGC as the Trust Multiplier:MarketScale’s model enabled the CEO and clinical founders to appear direct-to-camera, telling their story in their own words. This approach humanized the brand, cut through skepticism, and resonated with healthcare decision-makers.

Scalable Distribution:Content was placed where it would have the most impact:

• LinkedIn for peer-to-peer credibility

• Industry verticals focused on non-opioid solutions

• Digital hubs for surgeons, pain specialists, and rehab teams

Data-Driven Refinement:Real-time analytics identified the most resonant messages, guided adjustments for different specialties, and prioritized content for replication.

Impact & Industry Metrics

• Expanded Reach: Grew audience from early-adopter physicians to entire healthcare networks.

• Increased Demand: More inbound inquiries from surgical teams and rehab centers.

• Higher Engagement: UGC outperformed static content in click-through and watch rates, driven by authenticity and relatability.

Strategic Advantages

Challenge	Traditional Approach	Corganics’ UGC Approach
Credibility in Healthcare	Polished, corporate marketing	Founder-led, clinician-to-clinician storytelling
Audience Reach	Limited to in-person meetings	Scaled to national networks
Speed to Market	Slow, production-heavy processes	Rapid content creation and deployment
Message Resonance	Generic product claims	Clinical, human-centered narratives

Lessons & Recommendations

• Lead with Authenticity: Founder voices carry more weight than scripted marketing in healthcare.

• Prioritize Distribution: Reaching the right audience is as important as crafting the right message.

• Refine with Data: Use analytics to double down on what resonates most with your audience.

Conclusion

Through founder-led storytelling, targeted distribution, and continuous data refinement, Corganics turned its mission into a scalable, national conversation. At a time when the healthcare industry is actively seeking safer, clinically trusted pain management solutions, this approach positioned Corganics as a trusted leader and change-maker.